Denali Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Denali Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Denali Therapeutics Inc
Rating: 1.61541675
Author: Trendlyne DVM scores

about

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant ...

15.20 0.29 (1.95%)

54.40% Fall from 52W High

1.6M

XNAS Volume

XNAS 02 Oct, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.7 / 100

Technically Neutral

55.0 / 100

1Yr Price target upside is 161%

15 analysts

Denali Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Denali Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant ...

54.40% Fall from 52W High

SWOT Analysis

Denali Therapeutics Inc Live Price Chart